AADA successfully advocates for new diagnostic code
Moving the needle
January 1, 2024
DermWorld breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level.
The AADA advocated for you and got a new diagnostic code for reporting follow-up encounters for patients with malignant neoplasms. The approved ICD-10-CM code Z08 allows dermatologists to report primary diagnosis and proper history of malignant neoplasm treated for patient follow-up encounters after completed treatment for malignant neoplasms, even with no additional findings. These patients must not present with any other problem other than the history of malignant neoplasm.
In 2020, the AADA asked to create a new ICD-10-CM code set to report follow-up encounters after completed treatment for malignant neoplasm. After three years of advocacy, the Centers for Disease Control’s National Center for Vital Health Statistics approved our request on July 13, 2023.
Dermatologists were permitted to start reporting these encounters on Oct. 1, 2023. Learn more about reporting with code Z08.
More private payer help
Check out the Academy’s private payer resource center at staging.aad.org/private-payer.
Additional DermWorld Resources
In this issue
The American Academy of Dermatology is a non-profit professional organization and does not endorse companies or products. Advertising helps support our mission.
Opportunities
